These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12724722)
1. Cutaneous latanoprost in the treatment of alopecia areata. Mehta JS; Raman J; Gupta N; Thoung D Eye (Lond); 2003 Apr; 17(3):444-6. PubMed ID: 12724722 [No Abstract] [Full Text] [Related]
2. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows. Faghihi G; Andalib F; Asilian A Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039 [TBL] [Abstract][Full Text] [Related]
3. Successful use of bimatoprost in the treatment of alopecia of the eyelashes. Zaheri S; Hughes B Clin Exp Dermatol; 2010 Jun; 35(4):e161-2. PubMed ID: 19925481 [No Abstract] [Full Text] [Related]
4. An unusual anatomical colocalization of alopecia areata and vitiligo in a child, and improvement during treatment with topical prostaglandin E2. Yadav S; Dogra S; Kaur I Clin Exp Dermatol; 2009 Dec; 34(8):e1010-1. PubMed ID: 20055821 [No Abstract] [Full Text] [Related]
5. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. Coronel-Pérez IM; Rodríguez-Rey EM; Camacho-Martínez FM J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):481-5. PubMed ID: 20028444 [TBL] [Abstract][Full Text] [Related]
7. Treatment for facial alopecia areata: A systematic review with evidence-based analysis. Murad A; Bergfeld W J Am Acad Dermatol; 2018 Mar; 78(3):601-605. PubMed ID: 28987491 [No Abstract] [Full Text] [Related]
8. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata. Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023 [No Abstract] [Full Text] [Related]
9. Treatment of alopecia areata by topical diclofenac sodium gel in comparison to benzoyl peroxide gel. A novel single blind therapeutic clinical trial. Sharquie KE; Al-Nuaimy AA; Kadhum WJ Saudi Med J; 2006 Jul; 27(7):1079-81. PubMed ID: 16830041 [No Abstract] [Full Text] [Related]
10. Congenital alopecia areata. Lenane P; Pope E; Krafchik B J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):8-11. PubMed ID: 15692503 [TBL] [Abstract][Full Text] [Related]
11. Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata. Ross EK; Bolduc C; Lui H; Shapiro J J Am Acad Dermatol; 2005 Dec; 53(6):1095-6. PubMed ID: 16310083 [No Abstract] [Full Text] [Related]
12. Eyelash formation secondary to latanoprost treatment in a patient with alopecia. Mansberger SL; Cioffi GA Arch Ophthalmol; 2000 May; 118(5):718-9. PubMed ID: 10815168 [No Abstract] [Full Text] [Related]
18. Periocular pigmentation associated with use of travoprost for the treatment of alopecia areata of the eyelashes. Feletti F; Vincenzi C; Pazzaglia M; Tosti A J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):421-3. PubMed ID: 17309487 [No Abstract] [Full Text] [Related]
19. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata. Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558 [No Abstract] [Full Text] [Related]
20. A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata. Bhat S; Handa S; De D Indian J Dermatol Venereol Leprol; 2021; 87(1):42-48. PubMed ID: 33580923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]